Federal award
BIOMERIEUX INC
W91YTZ24C0014
Contract
Obligated and Ceiling
- Obligated (net)
- $258,222.69
- Ceiling (potential value, not spending)
- $641,337.53
- Current value
- $369,730.49
- Gross positive obligations
- $262,829.22
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOMERIEUX INC · HCNVCMEG9NL6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BIOMERIEUX INC · HCNVCMEG9NL6
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ24C0014
- Award type code
- D
- Actions
- 7 · Sep 20, 2024 to Jun 3, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 3, 2026 | FY2026 | P00006 | G | $0.00 | — |
| Apr 30, 2026 | FY2026 | P00005 | C | −$4,606.53 | — |
| Nov 24, 2025 | FY2026 | P00004 | C | $129,335.21 | — |
| Aug 26, 2025 | FY2025 | P00003 | C | $4,158.80 | — |
| Aug 14, 2025 | FY2025 | P00002 | G | $0.00 | — |
| Dec 2, 2024 | FY2025 | P00001 | C | $129,335.21 | — |
| Sep 20, 2024 | FY2024 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.